Skip to main content

J. Knipper and Company, Inc. Finalizes Acquisition of Eagle Pharmacy to Expand Company’s Pharmacy Programs, Scale and Automation Capabilities

One of the Largest Suppliers of Pharmaceutical Marketing Solutions and Specialty Pharmacy Services in the U.S. Closes Transaction to Acquire Full-Service, Direct-to-Patient Online PharmacyLAKEWOOD, N.J., Nov. 11, 2020 (GLOBE NEWSWIRE) — J. Knipper and Company, Inc., one of the largest suppliers of end-to-end pharmaceutical healthcare marketing services and solutions in the U.S., and its affiliates, including KnippeRx, announced today the Company has finalized a transaction to acquire Eagle Pharmacy, LLC, a full-service, direct-to-patient (DTP) pharmacy based in Lakeland, Florida.“Eagle Pharmacy represents a strategic acquisition for Knipper to accelerate delivery on its mission to enhance the patient journey and create the shortest distance between patient and therapy by offering customized pharmacy solutions to pharmaceutical manufacturers, payors, prescribers, and patients,” said Michael Laferrera, CEO of J. Knipper and Company. “This acquisition will combine technology, leadership, and customizable services with highly automated dispensing services to deliver innovative, scalable, and value-added offerings. Our clients – patients, prescribers, and manufacturers – can expect an enhanced offering of services and support from these two leaders in the pharmaceutical channel strategy space.”Eagle Pharmacy’s location in Lakeland, Florida adds state-of-the-art operational automation and scalability to KnippeRx’s current offerings, while providing pharmaceutical clients separation of customer pharmacy solutions under one trusted partner. Greater than 90 percent of enrollments completed by Eagle result in a shipment and clean orders are processed and shipped in less than one business day. With current operations at only 25 percent capacity, Eagle Pharmacy reaches about 200,000 patients a month, and supports more than 50 customized drug programs.“Eagle Pharmacy has earned an outstanding reputation in the pharmaceutical industry,” said Stacy Huss, President, Eagle Pharmacy. “Eagle’s drug manufacturer programs are supported by its home delivery pharmacy that has consistently demonstrated unparalleled patient safety and delivery of high-level service to patients, physicians and manufacturers. We are delighted to join J. Knipper and Company and are excited by the opportunity to leverage our combined expertise so that patients and prescribers can have a streamlined alternative to traditional pharmacy channels with transparent timelines and a host of online patient services.”Since its inception three years ago, KnippeRx has experienced rapid growth, responding to manufacturer needs by adding brand name, direct-to-patient programs to its pharmaceutical client offerings, including expansion of its biologic distribution, specialty dispensing and tech-enabled processing services. KnippeRx is one of the fastest growing providers of Patient Assistance Programs (PAP) services in the U.S. KnippeRx and Eagle Pharmacy are authorized to ship and dispense prescription medications throughout the U.S., the District of Columbia and U.S. territories.Bass Berry & Sims, PLC provided legal counsel to J. Knipper and Company, Inc. P&M Corporate Finance, LLC served as the exclusive financial advisor to Eagle Pharmacy and Baker Hostetler provided legal counsel.About J. Knipper and Company, Inc.J. Knipper and Company, Inc., one of the largest suppliers of end-to-end pharmaceutical samples management services in the U.S., has been purpose-built on a strong foundation of more than 30 years of healthcare service and excellence. The Company has locations throughout New Jersey and Indiana. For more information about J. Knipper and Company, please visit http://www.knipper.com.About KnippeRx Inc.KnippeRx is a highly nimble, independent specialty pharmacy that was purpose-built to overcome the complex barriers to access, providing the shortest possible path from initiation of script to delivery of essential therapy. As a patient-centric focused pharmacy, KnippeRx provides personalized patient assistance that includes PAP and starter dispensing of specialty therapies, high-touch biologics, and other products requiring temperature control. Our clear concentration enables us to provide exceptional services to manufacturers, patients, providers, and payers—in a manner never before offered in the specialty care environment. KnippeRx uniquely addresses the industry’s expressed need for increased speed to therapy and improved patient outcomes. We call it CARE. AT THE SPEED OF NEED.For more information about KnippeRx, please visit https://www.knipperx.com.About Eagle PharmacyEagle Pharmacy is a patient centric pharmacy that was founded in 2012 with the vision to create a direct-to-patient pharmacy for patients who choose to take a brand name medication but lack affordable access. Eagle Pharmacy supports the stringent storage and handling requirements of pharmaceutical manufacturers, which provides manufacturers greater control over their distribution channel. Eagle has grown to encompass numerous manufacturer programs each uniquely designed to ensure patient access to brand name medications. Eagle Pharmacy specializes in distribution channel strategies that account for the entire lifecycle of a product, from new brand launches to loss of exclusivity. By providing a bridge between manufacturers and patients, Eagle facilitates service offerings that help both physicians and patients overcome financial and access challenges. Eagle’s leadership team collectively has over 50 years of experience in the pharmacy industry, specifically related to pharmacy benefit managers, patient assistance programs, specialty, retail and mail order pharmacy operations as well as reimbursement support services programs. For more information about Eagle Pharmacy, please visit https://www.eaglepharmacy.com and https://www.eaglesfp.com.Contact:Lazar-FINN Partners
Glenn Silver, Healthcare Media Relations Specialist
646-871-8485

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.